Increased neuronal hypoxic tolerance induced by repetitive chemical hypoxia

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 22, Issue 2, 2002, Pages 132-134

  Li, Hongge ^a   Liu, Changqin ^a   Sun, Shenggang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

3 nitropropionate; Electrophysiology; Huntington's disease; Hypoxia

Indexed keywords

3-NITROPROPIONATE; HYPOXIA;

DISEASES; ELECTROPHYSIOLOGY;

NEUROLOGY;

3 NITROPROPIONIC ACID; 3-NITROPROPIONIC ACID; NITRO DERIVATIVE; PROPIONIC ACID DERIVATIVE;

ADAPTATION; ANIMAL; ARTICLE; CELL HYPOXIA; CYTOLOGY; DISEASE MODEL; HIPPOCAMPUS; HUNTINGTON CHOREA; ISCHEMIC PRECONDITIONING; MALE; MOUSE; NERVE CELL PLASTICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME; VASCULARIZATION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CELL HYPOXIA; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUNTINGTON DISEASE; ISCHEMIC PRECONDITIONING; MALE; MICE; NEURONAL PLASTICITY; NITRO COMPOUNDS; PROPIONIC ACIDS; TIME FACTORS;

EID: 3142640648     PISSN: 0257716X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. La Fontaine M A, Geddes J W, Banks A et al. 3-nitro-propionic acid induced in vivo protein oxidation in striatal and cortical synaptosomes: insights into Huntington's disease, Brain Res, 2000, 858: 356
2. Chyi T, Chang C. Temporal evolution of 3-nitropropionic acid-induced neurodegeneration in the rat brain by T2-weighted, diffusion-weighted, and perfusion magnetic resonance imaging. Neuroscience, 1999, 92: 1035
3. Gonszalez-Zulueta M, Feldman A B, Kiessee L J et al. Requirement for nitric oxide activation of p-21 (ras)/extracellular regulated kinase in neuronal ischemic preconditioning. Proc Natl Acad Sci USA, 2000, 97: 436
4. Riepe M W, Esclaire F, Kasischke K et al. Increased hypoxic and ischemic tolerance by chemical inhibition of oxidative phosphorylation: "chemical preconditioning". J Cereb Blood Flow Metab, 1997, 17: 257
5. Wiegand F, Liao W, Busch C et al. Respiratory chain inhibition induces tolerance to focal cerebral ischemia. J Cereb Blood Flow Metab, 1999, 19: 1229
6. Hamilton B F, Gould D H. Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage. Acta Neuropathol, 1987, 72: 286
7. Ludolph A C, Seelig M, Ludolph A et al. 3-nitropropionic acid decreases cellular energy levels and causes neuronal degeneration in cortical expiants. Neurodegeneration, 1992, 1: 155
8. Riepe M, Ludolph A, Seelig M et al. Protective effects of glutamate antagonists after inhibition of SDH are not caused by preservation of ATP levels. Neuroreport, 1994, 5: 2130
9. Riepe M W, Kasischike K, Gericke C A et al. Increase of hypoxic tolerance in rat hippocampal slices following 3-nitropropionic acid is not mediated by endogenous nerve growth factor. Neurosci Lett, 1996, 211: 9
10. Beai M F, Brouillet E, Jenkins B G et al. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci, 1993, 13: 4181
11. Moncayo J, De-Freitas G R, Bogousslavsky J et al. Do transient ischemic attacks have a neuroprotective effect? Neurology, 2000, 54: 2089
12. Beal M F, Hyman B T, Koroshetz W. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? TINS, 1993, 16: 125